Yong-Sang Song
Overview
Explore the profile of Yong-Sang Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
2004
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim H, Ju Y, Kim S, Park J, Kim H, Chung H, et al.
Gynecol Oncol
. 2023 Sep;
177:117-124.
PMID: 37660413
Objective: In 2014, the World Health Organization introduced a new histologic classification by dividing primary mucinous ovarian carcinoma (PMOC) into two: expansile (ES) or infiltrative subtypes (IS). This study investigated...
2.
Kim N, Kim S, Suh D, Kim H, Kim K, Chung H, et al.
Gynecol Oncol
. 2023 May;
174:224-230.
PMID: 37229880
Objective: Previously, we suggested that patients with cervical cancer (CC) with tumors ≤2 cm on preoperative magnetic resonance imaging (MRI) are safe candidates for laparoscopic radical hysterectomy (LRH). Here, we...
3.
Kim S, Hwangbo S, Dan K, Kim H, Chung H, Kim J, et al.
Mol Cell Proteomics
. 2023 Jan;
22(3):100502.
PMID: 36669591
Ovarian cancer is one of the most lethal female cancers. For accurate prognosis prediction, this study aimed to investigate novel, blood-based prognostic biomarkers for high-grade serous ovarian carcinoma (HGSOC) using...
4.
Kim S, Lee H, Yoon H, Kim H, Chung H, Kim J, et al.
BMC Cancer
. 2022 Sep;
22(1):965.
PMID: 36085013
Background: To evaluate the impact of intraoperative hypotension and hemodynamic instability on survival outcomes in patients with high-grade serous ovarian carcinoma (HGSOC). Methods: We retrospectively identified patients with HGSOC, who...
5.
Kim Y, Kim S, Kim H, Lee M, Kim H, Kim K, et al.
Gynecol Oncol
. 2022 Aug;
167(1):28-36.
PMID: 35970602
Objective: To compare survival outcomes of minimally invasive surgery (MIS) and open surgery for radical hysterectomy (RH) in early cervical cancer patients with histologic subtypes of usual-type adenocarcinoma and adenosquamous...
6.
Kim S, Lim H, Kim H, Chung H, Kim J, Park N, et al.
Cancer Res Treat
. 2022 Jul;
55(1):245-257.
PMID: 35879854
Purpose: This study aimed to investigate the impact of BRCA1/2 mutational status on survival outcomes in patients with platinum-sensitive relapsed (PSR) epithelial ovarian cancer (EOC). Materials And Methods: We retrospectively...
7.
Kim S, Choi B, Kim H, Chung H, Kim J, Park N, et al.
Gynecol Oncol
. 2021 Dec;
164(3):535-542.
PMID: 34969535
Objective: To ascertain whether cervical conization before radical hysterectomy (RH) has a protective effect on survival outcomes in early cervical cancer, taking into account the surgical approach. Methods: From cervical...
8.
Ha J, Jayaraman M, Yan M, Dhanasekaran P, Isidoro C, Song Y, et al.
Oncol Lett
. 2021 Aug;
22(4):719.
PMID: 34429759
With the focus on defining the oncogenic network stimulated by lysophosphatidic acid (LPA) in ovarian cancer, the present study sought to interrogate the oncotranscriptome regulated by the LPA-mediated signaling pathway....
9.
Kim S, Lee S, Choi C, Lee M, Suh D, Kim H, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359610
We purposed to develop machine learning models predicting survival outcomes according to the surgical approach for radical hysterectomy (RH) in early cervical cancer. In total, 1056 patients with 2009 FIGO...
10.
Kim S, Hwang W, Lee M, Kim H, Kim K, Chung H, et al.
BMC Cancer
. 2020 Dec;
20(1):1199.
PMID: 33287758
Background: To determine if extended chemotherapy improves survival outcomes in patients with platinum-sensitive relapsed epithelial ovarian cancer (EOC) who have residual disease after six cycles of second-line chemotherapy. Methods: In...